List Title | APhA DrugInfoLine

Focus on Diabetes Care

SORT BY: Most Recent Most Viewed

August 1, 2004

Triple Therapy Avoids Weight Gain in Type 2 Diabetes Mellitus

READ

PREVIEW
Patients with type 2 diabetes mellitus achieve better glycemic control without gaining weight when they receive triple therapy—insulin, metformin, and a thiazolidinedione—than with...
June 1, 2004

Initial Intensive Insulin Therapy in Type 2 Diabetes Mellitus

READ

PREVIEW
Initial intensive insulin therapy may rapidly control blood glucose levels and provide valuable prognostic information in newly diagnosed type 2 diabetes mellitus patients.
April 1, 2004

Comorbid Depression Affects Diabetic Control

READ

PREVIEW
Depression is an often unrecognized and underappreciated comorbid condition in patients with diabetes. Major depression is more likely in patients with diabetes who also have poorly controlled...
February 1, 2004

Food for Thought: Diet Makes a Big Difference

READ

PREVIEW
Diet is one of the basic lifestyle elements to address in preventing or treating diabetes, but two recent studies add a new dimension to just how far clinicians might go with dietary...
December 1, 2003

With Glitazones, Watch for Shortness of Breath, Other HF Symptoms

READ

PREVIEW
Thiazolidinediones should be used cautiously in patients at risk for heart failure (HF) and discontinued if suggestive symptoms emerge, according to a retrospective case–control study of...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.